182 related articles for article (PubMed ID: 24962033)
1. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
[TBL] [Abstract][Full Text] [Related]
4. Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.
Vivas M; Force E; Tubau F; El Haj C; Ariza J; Cabellos C
Int J Antimicrob Agents; 2015 Jul; 46(1):28-32. PubMed ID: 25813395
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
7. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
[TBL] [Abstract][Full Text] [Related]
8. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
[TBL] [Abstract][Full Text] [Related]
9. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
[TBL] [Abstract][Full Text] [Related]
12. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
[TBL] [Abstract][Full Text] [Related]
13. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
14. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
[TBL] [Abstract][Full Text] [Related]
15. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Grandgirard D; Schürch C; Cottagnoud P; Leib SL
Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
[TBL] [Abstract][Full Text] [Related]
16. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
Stucki A; Cottagnoud M; Winkelmann V; Schaffner T; Cottagnoud P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2249-52. PubMed ID: 17371817
[TBL] [Abstract][Full Text] [Related]
20. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
